Physician profile
Jay M Stanley
NPI 1184808677
$24,098.74
in general payments reported to CMS, 2019-2025
9 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $338 · 2020: $22.93 · 2021: $13K · 2022: $8,400 · 2023: $2,318 · 2024: $195 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,451 · Food and Beverage: $1,165.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,451.30 |
| Food and Beverage | $1,165.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $14,538.08 | 2019-2024 | |
| Arthrex, INC. | $4,523.97 | 2021 | |
| Stryker Corporation | $3,066.73 | 2019-2025 | Blueprint Patient Specific Instrumentation, Iconix, Alphavent |
| Medical Device Business Services, INC. | $909.81 | 2022 | |
| Smith+Nephew, INC. | $525.05 | 2023 | Microraptor, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Abbott Laboratories | $226.88 | 2020-2022 | |
| Depuy Synthes Sales INC. | $196.75 | 2019-2025 | Truespan Orthocord, Expressew, Healix Knotless Peek |
| Vericel Corporation | $84.98 | 2022-2024 | Maci |
| Pacira Pharmaceuticals Incorporated | $26.49 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Stanley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.